Rate of amputation · people with critical limb ischaemia
IM injection showed no clear difference in amputation rate Assessed during in‐patient stay compared with IA injection (low certainty).
1 finding from 1 review
Wound/ulcer healing: number of participants with healing ulcer · people with critical limb ischaemia
IM injection showed no clear difference in wound/ulcer healing: number of participants with healing ulcer compared with IA injection (low certainty).
1 finding from 1 review
Rest‐pain relief · people with critical limb ischaemia
IM injection showed no clear difference in reduction in rest pain: number of participants with reduction in… compared with IA injection (low certainty).
1 finding from 1 review
Ulcer healing · people with critical limb ischaemia
BM‐MNCs showed no clear difference in wound/ulcer healing: number of participants with healing ulcers… compared with mPBSCs (low certainty).
1 finding from 1 review
Rest‐pain relief · people with critical limb ischaemia
BM‐MNCs showed no clear difference in reduction in rest pain: number of participants with any reduction in… compared with mPBSCs (moderate certainty).
1 finding from 1 review
All‐cause mortality during hospital stay · people with critical limb ischaemia
1 finding from 1 review
Rate of amputation · people with critical limb ischaemia
1 finding from 1 review
Wound/ulcer healing: number of participants with healing ulcer · people with critical limb ischaemia
BM‐MNCs probably leads to higher wound/ulcer healing: number of participants with healing ulcers compared with BM‐MSCs (moderate certainty).
1 finding from 1 review
Deep vein thrombosis · prevention of venous thromboembolism in patients with lower‐limb immobilization
Low molecular weight heparin probably leads to lower deep venous thrombosis compared with no prophylaxis or placebo (moderate certainty).
1 finding from 1 review
Pulmonary embolism · prevention of venous thromboembolism in patients with lower‐limb immobilization
Low molecular weight heparin showed no clear difference in pulmonary embolism compared with no prophylaxis or placebo (low certainty).
1 finding from 1 review
Symptomatic venous thromboembolism · prevention of venous thromboembolism in patients with lower‐limb immobilization
Low molecular weight heparin may leads to lower symptomatic venous thromboembolism compared with no prophylaxis or placebo (low certainty).
1 finding from 1 review
Mortality due to pulmonary embolism · prevention of venous thromboembolism in patients with lower‐limb immobilization
1 finding from 1 review
Mortality due to other causes · prevention of venous thromboembolism in patients with lower‐limb immobilization
Low molecular weight heparin showed no clear difference in mortality due to other causes compared with no prophylaxis or placebo (low certainty).
1 finding from 1 review
Adverse outcomes · prevention of venous thromboembolism in patients with lower‐limb immobilization
Low molecular weight heparin showed no clear difference in adverse outcomes compared with no prophylaxis or placebo (low certainty).
1 finding from 1 review
Adherence to antipsychotic medication: number of missed doses, average endpoint data, short term (up to 6 months) · People receiving lipid‐lowering medications
Summary of findings table for the comparison of 'intensified patient… probably leads to higher medication adherence at ≤ 6 months compared with 'usual care' (moderate certainty).
1 finding from 1 review
Medication adherence (dichotomous) · People receiving lipid‐lowering medications
Summary of findings table for the comparison of 'intensified patient… leads to higher medication adherence at > 6 months compared with 'usual care' (high certainty).
1 finding from 1 review
LDL‐C reduction (LDL‐C) · People receiving lipid‐lowering medications
1 finding from 1 review
Reduction in total serum cholesterol at ≤ 6 months (mg/dL) · People receiving lipid‐lowering medications
1 finding from 1 review
Reduction in total serum cholesterol at > 6 mos (mg/dL) · People receiving lipid‐lowering medications
1 finding from 1 review
Intervention not reported
Incidence of any surgical site infection · lower limb arterial surgery
It is very uncertain whether the intervention changes incidence of any surgical site infection (very low certainty).
1 finding from 1 review